Table 1.
Compound | ΔΔGMOE | ΔΔGFEPa | ΔΔGFEPb | −Δ(pKd)experimentalc | ErrorFEPb |
---|---|---|---|---|---|
kcal/mol | kcal/mol | kcal/mol | kcal/mol | kcal/mol | |
3′-dATP | 0.1 | −1.6 | −0.5 | −0.5 | 0.0 |
7-Deaza-ATP | −7.6 | 1.3 | −0.2 | 0.8 | −2.0 |
2′-Deoxy-2′-fluoro-CTP | −4.4 | −0.4 | 0.2 | 1.1 | −0.9 |
2′-C-Methyl-CTP | −5.8 | 0.6 | 3.2 | 1.3 | 1.9 |
6-Methylpurine-TP | −19.3 | 0.3 | 1.2 | 1.6 | −0.4 |
3-Deaza-ATP | −1.3 | 2.5 | 0.1 | 1.7 | −1.6 |
2′-dATP | 1.0 | 0.0 | −0.2 | 1.8 | −2.0 |
2′-C-Methyl-ATP | 1.6 | 0.5 | 1.0 | 2.0 | −1.0 |
4′-Methyl-CTP | −10.4 | 3.7 | 1.1 | 2.0 | −0.9 |
2′-C-Methyl-GTP | 7.9 | 1.1 | 2.8 | 2.5 | 0.3 |
Ribavirin-TP | 11.9 | 2.5 | 3.7 | 3.0 | 0.7 |
a Calculated under the condition of H1125 having a neutral charge state.
b Calculated under the condition of H1125 having a +1 charge state.